Oyster Point Pharma, Inc. Unrecorded Unconditional Purchase Obligation, Purchases
Oyster Point Pharma, Inc. reported Unrecorded Unconditional Purchase Obligation, Purchases of $8.10 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Notes › Commitment and Contingencies
us-gaap:UnrecordedUnconditionalPurchaseObligationPurchases · last filed 2022-11-10
- 2022-09-30: Unrecorded Unconditional Purchase Obligation, Purchases 9 month $8.10M.
- 2021-09-30: Unrecorded Unconditional Purchase Obligation, Purchases 9 month $2.30M.
| Period end | Unrecorded Unconditional Purchase Obligation, Purchases 9 month |
|---|---|
| 2022-09-30 | $8.10M 10-Q · filed 2022-11-10 |
| 2021-09-30 | $2.30M 10-Q · filed 2022-11-10 |